Trial
NCT05403580
Olanzapine for the Treatment of Chronic Nausea and/or Vomiting in Patients With Advanced Cancer
Phase IIIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
—
Condition
Advanced Malignant Solid Neoplasm
Intervention
Olanzapine
Why stopped
Closed due to slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-06